| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $200,758,112 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | T32GM135741 | IMSD at UC Davis | 000 | 7 | NIH | 1/28/2026 | $832,529 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R33AG078471 | Creation of a monkey mini mental state exam (mMMSE) for identifying early cognitive deficits related to Alzheimer’s disease and related dementias | 000 | 4 | NIH | 7/2/2026 | $714,542 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA240751 | The Impact of Obesity on Radiotherapy Anti-Tumor Effects | 000 | 5 | NIH | 2/26/2026 | $539,696 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS073613 | Molecular-Genetic Dissection of Subcortical Circuitry Regulating Arousal | 001 | 14 | NIH | 3/3/2026 | $44,552 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DA056365 | High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction | 000 | 5 | NIH | 2/13/2026 | $541,161 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS073613 | Molecular-Genetic Dissection of Subcortical Circuitry Regulating Arousal | 000 | 14 | NIH | 1/21/2026 | $400,976 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | U01NS143225 | Clinical Outcome Assessment and Treatment Monitoring Markers for Clinical Trial Readiness in FXTAS | 001 | 2 | NIH | 6/25/2026 | $1,093,319 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS135005 | The electrical basis of proprioceptive signaling | 000 | 3 | NIH | 6/8/2026 | $476,507 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00AG071837 | Regional tau deposition and digital assessment of cognition in preclinical AD and MCI | 000 | 3 | NIH | 1/21/2026 | $112,700 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS144894 | Investigations of Spatial Recognition Memory to Improve Cognitive Outcomes in Epilepsy Surgery | 001 | 2 | NIH | 6/19/2026 | $612,244 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01HD114721 | Transitions in the acquisition of language in kids with Down Syndrome | 000 | 2 | NIH | 6/1/2026 | $846,259 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG075827 | Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease | 001 | 5 | NIH | 2/25/2026 | $71,249 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG075827 | Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease | 000 | 5 | NIH | 2/2/2026 | $641,241 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K23HD108353 | Machine Learning for CCHD Screening using Dynamic Data | 000 | 4 | NIH | 3/3/2026 | $81,696 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00NS133470 | Integration of seasonal cues to modulate neuronal plasticity | 000 | 4 | NIH | 7/6/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01HD114721 | Transitions in the acquisition of language in kids with Down Syndrome | 000 | 2 | NIH | 6/1/2026 | $250,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EB037526 | AI-Driven Digital Pathology Tool for Evaluating Inflammation and Therapeutic Efficacy in Preclinical Models | 000 | 2 | NIH | 6/9/2026 | $689,932 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01HL180444 | Pressure Regulation of Vascular CaV1.2 Channels | 000 | 2 | NIH | 6/24/2026 | $718,704 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K08CA288912 | Barriers and Facilitators for Delivery of Guideline-Concordant Care for Adolescents and Young Adults with Ewing Sarcoma and Osteosarcoma | 001 | 2 | NIH | 4/17/2026 | $28,278 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K08CA288912 | Barriers and Facilitators for Delivery of Guideline-Concordant Care for Adolescents and Young Adults with Ewing Sarcoma and Osteosarcoma | 000 | 2 | NIH | 1/23/2026 | $254,504 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01ES037032 | Molecular and Neurodevelopmental Alterations Associated with Prenatal Wildfire Exposures | 000 | 2 | NIH | 3/31/2026 | $683,232 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DE035429 | KSHV Replication and Trained Immunity | 000 | 2 | NIH | 6/16/2026 | $521,331 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01MH127046 | Neural and developmental trajectories of females with autism spectrum disorder | 000 | 5 | NIH | 3/2/2026 | $777,651 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DK124068 | Non-transcriptional regulation of circadian physiology | 000 | 7 | NIH | 1/28/2026 | $480,922 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21AI188129 | Role of the MIF/CD74 pathway in ILC2-driven airway hyperreactivity | 003 | 3 | NIH | 6/30/2026 | $241,500 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21CA299587 | Characterization of KSHV-Associated Disease Specific Gene Therapy | 000 | 2 | NIH | 2/26/2026 | $225,803 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F32GM159401 | Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy | 002 | 1 | NIH | 3/26/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F32GM159401 | Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy | 001 | 1 | NIH | 3/26/2026 | $1,308 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F32GM159401 | Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy | 000 | 1 | NIH | 3/19/2026 | $78,040 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31DC023776 | An articulatory brain-computer interface approach for restoring expressive communication to people with paralysis | 001 | 1 | NIH | 4/9/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31DC023776 | An articulatory brain-computer interface approach for restoring expressive communication to people with paralysis | 000 | 1 | NIH | 4/9/2026 | $43,752 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG094076 | Subjective cognitive decline as a risk for Alzheimer's disease and vascular cognitive impairment across diverse groups | 000 | 1 | NIH | 2/19/2026 | $690,934 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R03DE035523 | Cyclooxygenase signaling in neural crest migration and craniofacial development | 000 | 1 | NIH | 7/2/2026 | $301,086 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00CA256522 | Do Tumor-Immune Interactions Prime Systemic Tolerance of Triple-Negative Breast Cancer Brain Metastases? | 000 | 4 | NIH | 6/22/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R03EB038661 | Dynamic Imaging with Sparse Total-Body Positron Emission Tomography | 000 | 1 | NIH | 4/24/2026 | $161,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | UM1TR005995 | UC Davis Clinical and Translational Science Center | 000 | 1 | NIH | 5/12/2026 | $5,755,059 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EB039019 | Whole-Body PET Parametric Imaging for Pediatric Patients | 000 | 1 | NIH | 5/12/2026 | $2,238,460 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21MH141572 | Mechanisms of Satellite Oligodendroglia-Neuron Interaction in Brain Maturation | 000 | 1 | NIH | 6/22/2026 | $437,870 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K01DK143201 | Applying Implementation Science to Improve Transitions from Pediatric to Adult Care for Adolescents and Young Adults with Type 1 Diabetes | 000 | 1 | NIH | 5/7/2026 | $151,448 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00DC021504 | Taste perception of host cues in the invasive disease vector mosquito Aedes albopictus | 000 | 3 | NIH | 1/1/2026 | $238,502 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R35GM163701 | Causes and consequences of genome instability and chromosome rearrangements | 000 | 1 | NIH | 5/6/2026 | $435,405 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R35GM161914 | Decoding the Mechanisms and Regulatory Networks of Plant U-Box/RING Ubiquitin Ligase Complexes under biotic stress | 000 | 1 | NIH | 3/24/2026 | $390,881 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS131379 | Alpha-Synuclein aberrantly modifies the nanoscale distribution and function of ion channels to promote neuronal cytotoxicity | 000 | 2 | NIH | 3/31/2026 | $539,408 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | RF1NS144353 | SARS-CoV-2 potentiation of Tau pathology in a Rhesus macaque model of tauopathy | 000 | 1 | NIH | 7/7/2026 | $1,716,096 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG080591 | Patient and Family Member Reactions to Biomarker-Informed ADRD Diagnoses | 001 | 3 | NIH | 5/5/2026 | $3,920 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG080591 | Patient and Family Member Reactions to Biomarker-Informed ADRD Diagnoses | 000 | 3 | NIH | 3/30/2026 | $593,367 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AR085746 | Etiology and treatment for the skeletal defects caused by Spermine Synthase deficiency | 000 | 1 | NIH | 7/7/2026 | $596,378 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R25NS141153 | UC Davis NEURO Program | 000 | 1 | NIH | 5/18/2026 | $126,845 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21NS142879 | Optimization of AAV gene therapy through the unbiased, high-throughput screening of novel ITR domains in the mouse brain | 000 | 1 | NIH | 3/31/2026 | $442,750 |
|
